Clinical Trials Directory

Trials / Completed

CompletedNCT03619811

Precision Approach to PPI Therapy in Gastroesophageal Reflux Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
43 (actual)
Sponsor
University of California, San Diego · Academic / Other
Sex
All
Age
18 Years – 89 Years
Healthy volunteers
Accepted

Summary

This study plans to learn more about reflux associated laryngeal symptoms, and more efficient ways to diagnose and treat this condition.

Detailed description

Reflux associated laryngeal symptoms, coined "laryngopharyngeal reflux", occurs when gastro-esophago-pharyngeal reflux contributes to chronic laryngeal symptoms such as throat clearing, sore throat and dysphonia. Over the past 25 years, Reflux associated laryngeal symptoms has been increasingly, and often incorrectly, diagnosed and has emerged as a point of controversy and confusion.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTReflux Band® Upper Esophageal Sphincter (UES) Assist DeviceUES augmentation via the UES assist device is effective in true Reflux associated laryngeal symptoms. In our first pilot trial with the UES assist device, patients had significant symptom reduction following 2 weeks of UES assist device use. Based on our preliminary work, we theorize that the UES assist device is effective in Reflux associated laryngeal symptoms.

Timeline

Start date
2018-07-13
Primary completion
2021-06-30
Completion
2021-06-30
First posted
2018-08-08
Last updated
2021-09-20
Results posted
2021-09-20

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03619811. Inclusion in this directory is not an endorsement.